Table 2.
Respective critical values (P) and hazard ratios (HR) calculated via univariate cox proportional hazards regression analysis presented with presented with 95% Confidence Intervals (CI)
Factor | P | HR | 95% CI |
---|---|---|---|
Male | 0.428 | 1.59 | 0.50–5.02 |
Age (cont.) | 0.924 | 1.01 | 0.96–1.04 |
Age ≥ 55 | 0.966 | 1.04 | 0.33–3.19 |
Rate of growth | 0.904 | 0.94 | 0.33–2.57 |
Duration of symptoms | 0.534 | 1.01 | 0.98–1.05 |
Pain | 0.151 | 0.41 | 0.08–2.03 |
Tumor size (cont.) | 0.151 | 1.21 | 0.94–1.54 |
Size < 4.9 cm | 0.39 | 0.38 | 0.11–1.04 |
Size 5.0–9.9 cm | 0.967 | 0.76 | 0.41–1.89 |
Size ≥ 10 cm | 0.955 | 1.34 | 0.86–1.98 |
Mitotic activity (cont.) | 0.354 | 1.04 | 0.96–1.12 |
Mitotic activity ≥ 4/10 hpf | 0.291 | 0.40 | 0.07–2.19 |
Positive margins | < 0.001 | 0.069 | 0.02–0.27 |
Atypia, hemorrhage, or necrosis | 0.088 | 0.36 | 0.07–1.26 |
Local invasion | 0.079 | 0.34 | 0.08–1.15 |
Bold values indicate statistical significance
cont. continuously tested variable, hpf high powered field